Henry Byabajungu

Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania

N. Range, M. Hoelscher, M. Joloba, 2022, BMC Genomics.

First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda

Isam Adam, M. Joloba, G. Mboowa, 2021, Antimicrobial resistance and infection control.

Second-line drug resistance markers as proxy indicators of time to sputum culture conversion among second-line drug resistant tuberculosis patients tested in Uganda: A cross-sectional study

M. Joloba, W. Ssengooba, J. Phelan, 2023, F1000Research.

Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda

W. Katagira, I. Kimuli, M. Joloba, 2021, Journal of clinical tuberculosis and other mycobacterial diseases.

Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review

M. Joloba, W. Ssengooba, J. Phelan, 2022, BMC Infectious Diseases.